Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): Complete Statistical AnalysisIndependent statistical analysis of Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention: Complete Statistical AnalysisIndependent statistical analysis of Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GET-PrEPDIndependent statistical analysis of Goal Elicitation, Treatment Prioritization, & Electronically-Practiced Discussion for Psychiatry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04601194).
- GETGOAL-L-ASIAIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA): primary endpoint results, effect…
- GetGoal-OIndependent statistical analysis of Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients: primary endpoint results, effect estimate with…
- GETUGV04Independent statistical analysis of A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GIFTIndependent statistical analysis of Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03358355).
- GINGERIndependent statistical analysis of Ginger's Therapeutic Potential in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03705832).
- Ginger Capsules for the Acute Treatment of Migraine Attacks: Complete Statistical AnalysisIndependent statistical analysis of Ginger Capsules for the Acute Treatment of Migraine Attacks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02568644).
- GIVERIndependent statistical analysis of Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GKT137831Independent statistical analysis of GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03865927).
- GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study: Complete Statistical AnalysisIndependent statistical analysis of GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02525861).
- Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- GLIDERIndependent statistical analysis of A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS): primary endpoint results, effect estimate…
- GlideScope Versus Direct Laryngoscope for Emergency Intubation: Complete Statistical AnalysisIndependent statistical analysis of GlideScope Versus Direct Laryngoscope for Emergency Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01235065).
- Glimepiride 4 mg Tablets Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Glimepiride 4 mg Tablets Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835172).
- GLITTER 2Independent statistical analysis of Gan & Lee Insulin Glargine Target Type (2) Evaluating Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03371108).
- Global Prospective Case Series Using a Single-Use Duodenoscope: Complete Statistical AnalysisIndependent statistical analysis of Global Prospective Case Series Using a Single-Use Duodenoscope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04103749).
- Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: Complete Statistical AnalysisIndependent statistical analysis of Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- GLOW7Independent statistical analysis of Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight: Complete Statistical AnalysisIndependent statistical analysis of GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GLS-5700 in Dengue Virus-Naïve Adults: Complete Statistical AnalysisIndependent statistical analysis of GLS-5700 in Dengue Virus-Naïve Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02809443).
- Glucagon Use in Colonoscopies: Complete Statistical AnalysisIndependent statistical analysis of Glucagon Use in Colonoscopies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02078726).
- Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong – Darmstadt): Complete Statistical AnalysisIndependent statistical analysis of Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03566810).
- Glucose Counterregulation in Long Standing Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Glucose Counterregulation in Long Standing Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01474889).
- Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients: Complete Statistical AnalysisIndependent statistical analysis of Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03091673).
- GlulipidIndependent statistical analysis of Glucose and Lipid Metabolism on Antipsychotic Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515723).
- GLUMIT-DGIndependent statistical analysis of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030341).
- Glutamate Reducing Interventions in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Glutamate Reducing Interventions in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03321617).
- GLUTAMICSIndependent statistical analysis of Glutamate for Metabolic Intervention in Coronary Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00489827).
- Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size…
- Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD: Complete Statistical AnalysisIndependent statistical analysis of Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD: primary endpoint results, effect estimate with confidence interval,…
- GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- GMRx2_PCTIndependent statistical analysis of Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GMTIndependent statistical analysis of Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02486263).
- GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC: Complete Statistical AnalysisIndependent statistical analysis of GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GO2 PEEPIndependent statistical analysis of Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GOALIndependent statistical analysis of Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GOCIndependent statistical analysis of Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GOLDEN-3Independent statistical analysis of Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- GOLMePsAIndependent statistical analysis of GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04108468).
- GonoScreenIndependent statistical analysis of GonoScreen: Efficacy of Screening STIs in MSM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04269434).
- GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry: Complete Statistical AnalysisIndependent statistical analysis of GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02266342).
- GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): Complete Statistical AnalysisIndependent statistical analysis of GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04706273).
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00540722).
- Gout in the ED and Improving Research Participation: Complete Statistical AnalysisIndependent statistical analysis of Gout in the ED and Improving Research Participation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04075903).